LungLife AI: Funding, Investors & Team (Sep 2026)
LungLife AI is a molecular diagnostics company dedicated to detecting and treating cancer early. Using machine learning and artificial intelligence, the company is able to provide life-saving early diagnosis of lung cancer. Their focus is on revolutionizing cancer diagnosis and management by utilizing AI for molecular analysis of cancer biomarkers in blood. LungLife AI is working on tests for all stages of lung cancer, from aiding in early diagnosis to monitoring late-stage disease. Through their diagnostic technology and machine learning techniques, the company is able to improve workflow efficiency and performance. Established in 2008, LungLife AI is based in Thousand Oaks, California.
LungLife AI has raised $320k across 1 funding round on record, the most recent an undisclosed round of $320k announced in Mar 2024.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
LungLife AI Company Profile and Key Stats
Latest funding round on record: Mar 2024.
LungLife AI Funding Rounds
LungLife AI Founders and Leadership Team
No contact details are on record for this team yet.
LungLife AI Funding Compared to Other Artificial Intelligence Startups
LungLife AI's latest round of $320k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LungLife AI in Artificial Intelligence and Thousand Oaks
Companies Similar to LungLife AI
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
LungLife AI Funding FAQs
What does LungLife AI do?
LungLife AI is a molecular diagnostics company dedicated to detecting and treating cancer early. Using machine learning and artificial intelligence, the company is able to provide life-saving early diagnosis of lung cancer. Their focus is on revolutionizing cancer diagnosis and management by utilizing AI for molecular analysis of cancer biomarkers in blood. LungLife AI is working on tests for all stages of lung cancer, from aiding in early diagnosis to monitoring late-stage disease. Through their diagnostic technology and machine learning techniques, the company is able to improve workflow efficiency and performance. Established in 2008, LungLife AI is based in Thousand Oaks, California.
How much funding has LungLife AI raised?
LungLife AI has raised $320k across 1 round on record. The most recent is an undisclosed round of $320k announced in Mar 2024.
When did LungLife AI last raise funding?
LungLife AI's most recent funding round on record is an undisclosed round of $320k, announced in Mar 2024.
Who founded LungLife AI?
FundedIQ lists Fred Gluck (Founder) at LungLife AI.
Where is LungLife AI headquartered?
LungLife AI is based in Thousand Oaks, California, United States.
How many employees does LungLife AI have?
LungLife AI is in the 11-50 employee band.
How does LungLife AI's funding compare to other Artificial Intelligence startups?
LungLife AI's latest round of $320k is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's LungLife AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LungLife AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.